118 related articles for article (PubMed ID: 26459463)
1. [Randomised comparison of stereotactic body radiotherapy versus lobectomy in stage I NSCLC--level I evidence at last?].
Guckenberger M; Andratschke N
Strahlenther Onkol; 2015 Dec; 191(12):988-90. PubMed ID: 26459463
[No Abstract] [Full Text] [Related]
2. Lobectomy versus stereotactic body radiotherapy for stage I non-small cell lung cancer: Post hoc analysis dressed up as level-1 evidence?
Meyers BF; Puri V; Broderick SR; Samson P; Keogan K; Crabtree TD
J Thorac Cardiovasc Surg; 2015 Sep; 150(3):468-71. PubMed ID: 26259993
[No Abstract] [Full Text] [Related]
3. Stereotactic radiotherapy or surgery for early-stage non-small-cell lung cancer.
Katz MS; Husain ZA
Lancet Oncol; 2016 Feb; 17(2):e41-e42. PubMed ID: 26868347
[No Abstract] [Full Text] [Related]
4. Stereotactic radiotherapy or surgery for early-stage non-small-cell lung cancer - Authors' reply.
Chang JY; Senan S; Smit EF; Roth JA
Lancet Oncol; 2016 Feb; 17(2):e42-e43. PubMed ID: 26868349
[No Abstract] [Full Text] [Related]
5. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.
Chang JY; Senan S; Paul MA; Mehran RJ; Louie AV; Balter P; Groen HJ; McRae SE; Widder J; Feng L; van den Borne BE; Munsell MF; Hurkmans C; Berry DA; van Werkhoven E; Kresl JJ; Dingemans AM; Dawood O; Haasbeek CJ; Carpenter LS; De Jaeger K; Komaki R; Slotman BJ; Smit EF; Roth JA
Lancet Oncol; 2015 Jun; 16(6):630-7. PubMed ID: 25981812
[TBL] [Abstract][Full Text] [Related]
6. SABR vs surgery for NSCLC in the media.
Rice D; Sepesi B; Heymach J; Swisher S; Vaporciyan A
Lancet Oncol; 2015 Sep; 16(9):e422. PubMed ID: 26370343
[No Abstract] [Full Text] [Related]
7. Surgery versus SABR for resectable non-small-cell lung cancer.
Hamaji M; Groth SS; Sugarbaker DJ; Burt BM
Lancet Oncol; 2015 Aug; 16(8):e372. PubMed ID: 26248839
[No Abstract] [Full Text] [Related]
8. Surgery versus SABR for resectable non-small-cell lung cancer.
Opitz I; Rocco G; Brunelli A; Varela G; Massard G; Weder W;
Lancet Oncol; 2015 Aug; 16(8):e372-3. PubMed ID: 26248838
[No Abstract] [Full Text] [Related]
9. Surgery versus SABR for resectable non-small-cell lung cancer.
Zhang L; Tian J; Wang C
Lancet Oncol; 2015 Aug; 16(8):e371-2. PubMed ID: 26248837
[No Abstract] [Full Text] [Related]
10. Surgery versus SABR for resectable non-small-cell lung cancer.
Cao C; D'Amico T; Demmy T; Dunning J; Gossot D; Hansen H; He J; Jheon S; Petersen RH; Sihoe A; Swanson S; Walker W; Yan TD;
Lancet Oncol; 2015 Aug; 16(8):e370-1. PubMed ID: 26248836
[No Abstract] [Full Text] [Related]
11. Surgery versus SABR for resectable non-small-cell lung cancer - Authors' reply.
Chang JY; Senan S; Smit EF; Roth JA
Lancet Oncol; 2015 Aug; 16(8):e374-5. PubMed ID: 26248841
[No Abstract] [Full Text] [Related]
12. SABR in early operable lung cancer: time for evidence.
Treasure T; Rintoul RC; Macbeth F
Lancet Oncol; 2015 Jun; 16(6):597-8. PubMed ID: 25981817
[No Abstract] [Full Text] [Related]
13. Do we know bad science when we see it?
Jones DR
J Thorac Cardiovasc Surg; 2015 Sep; 150(3):472-3. PubMed ID: 26254751
[No Abstract] [Full Text] [Related]
14. Surgery versus SABR for resectable non-small-cell lung cancer.
Dearman C; van As N; Crellin A; Slevin N; Sharma RA
Lancet Oncol; 2015 Aug; 16(8):e373-4. PubMed ID: 26248840
[No Abstract] [Full Text] [Related]
15. Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer.
Rosen JE; Salazar MC; Wang Z; Yu JB; Decker RH; Kim AW; Detterbeck FC; Boffa DJ
J Thorac Cardiovasc Surg; 2016 Jul; 152(1):44-54.e9. PubMed ID: 27131846
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of stereotactic body radiotherapy and surgery for medically operable early stage non small cell lung cancer.
Paix A; Noel G; Falcoz PE; Levy P
Radiother Oncol; 2018 Sep; 128(3):534-540. PubMed ID: 29706462
[TBL] [Abstract][Full Text] [Related]
17. [Lobectomy for local recurrence following stereotactic radiotherapy to non-small cell lung cancer].
Neri S; Kitamura J; Komatsu T; Takahashi Y; Takeshima Y; Kaji R; Hayashi M; Nishimura T; Tomii K; Katakami N; Ishihara K; Kokubo M
Kyobu Geka; 2009 Aug; 62(9):812-5. PubMed ID: 19670785
[TBL] [Abstract][Full Text] [Related]
18. Video-assisted thoracoscopic lobectomy versus stereotactic radiotherapy for stage I lung cancer.
Hamaji M; Chen F; Matsuo Y; Kawaguchi A; Morita S; Ueki N; Sonobe M; Nagata Y; Hiraoka M; Date H
Ann Thorac Surg; 2015 Apr; 99(4):1122-9. PubMed ID: 25661580
[TBL] [Abstract][Full Text] [Related]
19. Local Therapy for Limited Metastatic Non-Small Cell Lung Cancer: What Are the Options and Is There a Benefit?
Iyengar P; Lau S; Donington JS; Suh RD
Am Soc Clin Oncol Educ Book; 2016; 35():e460-7. PubMed ID: 27249754
[TBL] [Abstract][Full Text] [Related]
20. If at First You Don't Succeed-Stereotactic Body Radiation Therapy for Recurrent Non-Small Cell Lung Cancer.
Owen D; Siva S; Salama JK; Robinson C; Kruser TJ; Giuliani M
Int J Radiat Oncol Biol Phys; 2022 Sep; 114(1):5-9. PubMed ID: 35964631
[No Abstract] [Full Text] [Related]
[Next] [New Search]
